2007. | Oct. | The 1st Regular Meeting (Mielparque-Kyoto) Theme: Decision making of tumor-margin distance of breast conservation surgery (BCS) and following reexcision in patients with positive margins |
2008. | Feb. | The 2nd Regular Meeting (Kyoto Tokyu Hotel) Theme: Primary Systemic Chemotherapy (PST) and Operation following PST |
2008. | Jun. | The 3rd Regular Meeting (Kyoto Hotel Okura) Theme: The Adjuvant Chemotherapy and The Type of Recurrence on the Hormonal Receptor Negative Breast Cancer |
2008. | Oct. | The 4th Regular Meeting (Kyoto Tokyu Hotel) Theme: The Controversy behind Radiation Therapy |
2008. | Oct. | Authorized by Kyoto Government |
2009. | Jan. | The 5th Regular Meeting (The Westin Miyako, Kyoto) Theme: Partnership of Breast Cancer Surgery and the Pathologist ~aiming toward more accurate diagnosis~ |
2009. | Apr. | Kyoto Breast Cancer Consensus Conference 2009 International Convention (Kyoto International Conference Center) |
2009. | Jul. | The 6th Regular Meeting (The Westin Miyako, Kyoto) Theme: Breast Cancer Biomarker - Individualized Medical Treatment by Preoperative Chemotherapy |
2010. | Jan. | The 7th Regular Meeting (The Westin Miyako, Kyoto) Theme: From breast MRI imaging/diagnosis to clinical utilization |
2010. | Apr. | "Local and Systemic Management of Primary Breast Cancers" by Masakazu Toi and Eric P. Winer (eds.) is publised by Kyoto University Press. |
2010. | May. | The 8th Regular Meeting (The Westin Miyako, Kyoto) Theme: Clinical / Pathology of Contralateral Breast Cancer |
2010. | Jun. | Lecture "Challenges for the Surgeon and Oncologist in Neoadjuvant Therapy, Updates from the USA trials" by Mehra Golshan (Mielparque Kyoto) |
2010. | Jun. | KBCCC satellite conference in Hokkaido (Grand Park Otaru) Theme: Diagnostic imaging of preoperative medication and operative therapy - adoption of MRI volumetry |
2010. | Oct. | The 9th Regular Meeting (The Westin Miyako, Kyoto) Theme: Biology of DCIS |
2011. | Jan. | The 10th Regular Meeting (The Westin Miyako, Kyoto) Theme: Presurgical Treatment of Luminal Breast Cancer |
2011. | Apr. | Kyoto Breast Cancer Consensus Conference 2011 International Convention (Kyoto International Conference Center) |
2011. | Jun. | The 11th Regular Meeting (The Westin Miyako, Kyoto) Theme: Regional Cooperation and Postsurgical Follow-up |
2011. | Nov. | The 12th Regular Meeting (The Westin Miyako, Kyoto) Theme: Anti-HER2 Therapy in Trastuzmab-Registant Breast Cancer |
2012. | Feb. | The 13th Regular Meeting (The Westin Miyako, Kyoto) Theme: Individualized treatment of primary breast cancer |
2012. | May. | The 14th Regular Meeting (The Westin Miyako, Kyoto) Theme: Current status and perspective of axillary treatments |
2012. | Oct. | The 15th Regular Meeting (The Westin Miyako, Kyoto) Theme: Positioning of metronomic therapy |
2013. | Feb. | The 16th Regular Meeting (The Westin Miyako, Kyoto) Theme: Combined Modality Therapy of bone metastasis from breast cancer |
2013. | Apr. | The 17th Regular Meeting (The Westin Miyako, Kyoto) Theme: Angiogenesis and Chemotherapy |
2013. | Sept. | The 18th Regular Meeting (The Westin Miyako, Kyoto) Theme: Hormonal Systemic Control and Fertility |
2014. | Feb. | Kyoto Breast Cancer Consensus Conference 2014 International Convention (Westin Miyako Kyoto) |
2014. | Feb. | Society of Surgical Oncology (SSO) has given an award as a partner |
2014. | Mar. | The 19th Regular Meeting (The Westin Miyako, Kyoto) Theme: Young Breast Cancer Patients |
2014. | Jul. | The 20th Regular Meeting (The Westin Miyako, Kyoto) Theme: Breast Reconstruction and Oncoplastic Surgery |
2014. | Nov. | The 21st Regular Meeting (Shiran Hall, Kyoto University) Theme: Anticancer Drug Treatment of HER2 Negative Recurrent Breast Cancer |
2015. | Apr. | The 22nd Regular Meeting (Shiran Hall, Kyoto University) Theme: Treatment of Hormone Resistant Recurrent Cancer |
2015. | Sep. | The 23rd Regular Meeting (Shiran Hall, Kyoto University) Theme: HER2 positive recurrent breast cancer |
2016. | Mar. | Kyoto Breast Cancer Consensus Conference 2016 International Convention (Co-hosted with OOTR 12th Annual Conference, AOS 2016) (Westin Miyako Hotel, Kyoto) |
2016. | Apr. | The 24th Regular Meeting (Shiran Hall, Kyoto University) Theme: Radiotherapy |
2016. | Sept. | The 25th Regular Meeting (Shiran Hall, Kyoto University) Theme: Long-term survival in breast cancer recurrence |
2017. | May. | The 26th Regular Meeting (Hotel Hanshin) Theme: Long-term/Extended Hormone, Dose-dense Therapy, Bevacizumab, HER2 Update and Axillary Dissection |
2017. | Sep. | The 27th Regular Meeting (The Westin Miyako Kyoto) Theme: Optical ultrasonic, Microwave, Treatment of stage IV, Treatment of recurrent breast cancer |
2018. | Mar. | The 28th Regular Meeting (Hotel Hanshin) Theme: 'Problems about diagnostic pathology of breast' (1. Sub-classification of TNBC, 2. Definition of infiltrating lobular carcinoma, 3. How to measure a diameter of infiltrate), Luminal recurrence therapy, Hormonal sensitivity / tolerance, Remove of primary metastases in stage 4 / local management of metastatic lesion (radiology), Treatment of aged breast cancer |
2018. | May. | Kyoto Breast Cancer Consensus Conference 2018 International Convention (Conjunction with the 26th Japanese Breast Cancer Society Meeting) (Kyoto International Conference Center) |
2018. | May. | The 26th Japanese Breast Cancer Society Meeting Public Lecture (Kyoto International Conference Center) |
2018. | Sep. | The 29th Regular Meeting (The Westin Miyako Kyoto) Theme: The actual situation of CDK4/6, Clinical sequence, PARP inhibitor, Treatment of stage IV, Treatment of recurrent breast cancer, Adverse event prediction of aged breast cancer |
2019. | May. | The 30th Regular Meeting (Hotel Hanshin) Theme: Breast cancer late relapse, Relationship between PFS and OS, The actual situation of hereditary breast cancer |
2019. | Sep. | The 31th Regular Meeting (Inamori Hall, Shirankaikan, Kyoto University) Theme: Actual situation of evaluation of TIL and PD-L1 expression in tumor tissues, Hypofractionated radiation therapy, reatment of locally advanced / Stage IV, Treatment for senior citizens and overtreatment, Diversity of breast cancer and the treatment selection |